285,286 Collectively, GLP-1 RAs integrate metabolic, anti-inflammatory, and neuroprotective mechanisms, representing a promising strategy to promote healthier aging, enhance cognitive resilience, and extend healthspan across multiple organ systems
While GLP-1 receptor agonists were developed to treat type 2 diabetes, many have demonstrated significant weight loss or weight maintenance effects
It is typically well-tolerated, but side effects such as gastrointestinal discomfort, pancreatitis, and thyroid concerns require careful monitoring
Our mission is to restore strength, mobility, and independence
D50.0 Iron Deficiency Anemia Due to Chronic Blood Loss This code applies to long-term bleeding scenarios in which the patient loses small amounts of blood over weeks or months